In recent months it has emerged that the novel coronavirus—responsible for the COVID-19
pandemic—causes reduction of smell and taste in a large fraction of patients. The …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause chronic and
acute disease. Postacute sequelae of SARS-CoV-2 infection (PASC) include injury to the …

Objective To investigate prevalence and recovery of olfactory dysfunction (OD) in COVID‐19
patients according to the disease severity. Methods From 22 March to 3 June 2020, 2581 …

The novel coronavirus disease 2019 (COVID‐19) emerged in late December 2019 in china
and has rapidly spread to many countries around the world. The effective pharmacotherapy …

Background There is limited understanding of the characteristics of patients with coronavirus
disease 2019 (COVID-19) requiring hospitalization in Japan. Methods This study included …

A significant proportion of people who test positive for COVID-19 have chemosensory
deficits. However, the reported prevalence of these deficits in smell and taste varies widely …

The Coronavirus Disease 2019 (COVID-19) pandemic, now a global health crisis, has
surprised health authorities around the world. Recent studies suggest that the measures …

Common manifestations of COVID-19 are respiratory and can extend from mild symptoms to
severe acute respiratory distress. The severity of the illness can also extend from mild …

BackgroundThe long-term recovery rate of chemosensitive functions in coronavirus disease
2019 patients has not yet been determined. MethodA multicentre prospective study on 138 …

In late December 2019, a series of acute atypical respiratory disease occurred in Wuhan,
China, which rapidly spread to other areas worldwide. It was soon discovered that a novel …